Disease: Hereditary angioedema
- A 42-Year Delay in Diagnosing Hereditary Angioedema: A Case Report
- A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment
- A core outcome set for efficacy of acute treatment of hereditary angioedema
- A Cross-Sectional Study of Quality of Life in Patients Enrolled in the Romanian Hereditary Angioedema Registry
- A mechanism for hereditary angioedema caused by a methionine-379 to lysine substitution in kininogens
- A mechanism for hereditary angioedema caused by a methionine-379-to-lysine substitution in kininogens
- A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema
- AN ADOLESCENT CASE OF HAE-NL-C1INH (WHO WAS) MISDIAGNOSED WITH WHEAT ALLERGY AND MULTIPLE DRUG ALLERGIES
- An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy
- Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema
- Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial
- Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
- Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center
- C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
- Cardiovascular Autonomic Nervous System in a Patient With Hereditary Angioedema Affected by COVID-19
- Case series of hereditary angioedema patients and use of tranexamic acid treatments in prophylaxis and acute crisis, experience in Peru
- Clinical Characteristics and Quality of Life in a Cohort of Polish Pediatric Patients with Hereditary Angioedema
- Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series
- Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema
- Comorbidities in Angioedema Due to C1-Inhibitor Deficiency: An Italian Survey
- Complex analysis of the national Hereditary angioedema cohort in Slovakia - Identification of 12 novel variants in SERPING1 gene
- Contactless edema via plasmin
- COVID-19 and vaccination in hereditary angioedema: Single center experience
- CRISPR-Cas9 In Vivo Gene Editing of <em>KLKB1</em> for Hereditary Angioedema
- CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema
- Delay in diagnosis is the most important proximate reason for mortality in hereditary angio-oedema: our experience at Chandigarh, India
- Delays in diagnosis is the commonest proximate reason for mortality in hereditary angioedema: our experience at Chandigarh, India
- Design and implementation of a transdisciplinary care model for patients with hereditary angioedema, in a Colombian health institution
- Design, expression and biological evaluation of DX-88mut as a novel selective factor XIa inhibitor for antithrombosis
- Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: A randomized-controlled trial
- Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein
- Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases
- Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
- Efficacy outcomes in trials with prophylactic hereditary angioedema therapy: A systematic review
- Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan
- Epidemiology and treatment of children with hereditary angioedema in Germany: A retrospective database study
- Experiencia inicial de Lanadelumab en una paciente mexicana con angioedema hereditario tipo I
- Exploring the Relationship Between Tamoxifen and Hereditary Angioedema
- Extremely Late Diagnosis of Hereditary Angioedema Type I in an Elderly Female
- Functional Characterization of Two Novel Intron 4 <em>SERPING1</em> Gene Splice Site Pathogenic Variants in Families with Hereditary Angioedema
- Functional Characterization of Two Novel Intron 4 SERPING1 Gene Splice Site Pathogenic Variants in Families with Hereditary Angioedema
- Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme
- Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat
- Hereditary angioedema with a normal C1 inhibitor in Japanese man
- Hereditary Angioedema With a Normal Complement Level
- Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency
- Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families
- Hereditary angioedema: do patients have a specific "digital fingerprint" in Danish registries?
- Hereditary angioedema: Patient journey approach in Mexico
- Hereditary or acquired? Comprehensive genetic testing assists in stratifying angioedema patients
- Homozygous missense variant F12 (Gly506Asp) associated with severe factor XII deficiency: a case report
- Hong Kong-Macau Severe Hives and Angioedema Referral Pathway
- Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency
- In vivo CRISPR agent cuts HAE attacks 95
- Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) as a Compensatory Protease Inhibitor in Hereditary Angioedema (HAE)
- Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies
- Large-Bowel Obstruction from Hereditary Angioedema
- Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema
- Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
- Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema
- Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
- Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders
- Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study
- Novel genetic modifiers of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency
- Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy
- Now You See Me: Acute and Recurrent Severe Abdominal Pain Associated With Bowel Edema
- Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial
- Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation
- Pathogenic variant in <em>SERPING1</em> gene causing autosomal dominant hereditary angioedema in early childhood
- Pathogenic variant in SERPING1 gene causing autosomal dominant hereditary angioedema in early childhood
- Pathophysiology of bradykinin and histamine mediated angioedema
- Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis
- Plasma microRNAs as biomarkers in hereditary angioedema
- Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
- Prodromal symptoms of hereditary angioedema (HAE) attacks: A patient survey in UK and Spain
- Prophylaxis in hereditary angioedema: a United Kingdom Delphi consensus
- Pseudo-Allergies in the Emergency Department: A Common Misdiagnosis of Hypersensitivity Type 1 Allergic Reaction
- Real-life experience of subcutaneous (SC) plasma derived C1-inhibitor (pdC1INH) as long-term prophylaxis (LTP) in HAE-C1INH
- Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks
- Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system
- Recessive <em>SERPING1</em> Variant Leads to Kinin-Kallikrein System Control Failure in a Consanguineous Brazilian Family with Hereditary Angioedema
- Recessive SERPING1 Variant Leads to Kinin-Kallikrein System Control Failure in a Consanguineous Brazilian Family with Hereditary Angioedema
- Registry of Members of the Association of Patients with Hereditary Angioedema of Peru
- Repeated attacks of hereditary angioedema in pediatric female
- Reply to "A Case Report about the Management of Hereditary Angioedema with Normal Complement Levels during Pregnancy"
- Screening for type II hereditary angioedema-the "poor man's c1-inhibitor function"
- Successful Pregnancy Outcome in a Hereditary Angioedema Patient With Previous Pregnancy Losses: A Proposed Delivery Plan
- Summary and future of medicine for hereditary angioedema
- The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II
- The current situation of hereditary angioedema patients in Germany: results of an online survey
- The Definition, Acronyms, Nomenclature, and Classification of Angioedema: AAAAI, ACAAI, ACARE, and APAACI DANCE Consensus
- The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec
- The effect of estrogen-containing birth control pills on the constituents of bradykinin expression in plasma
- The Future of Therapeutic Options for Hereditary Angioedema
- The Importance of Patient Empowerment: A Clinical Case of Hereditary Angioedem
- The role of anxiety in patients with hereditary angioedema during oral treatment: a narrative review
- Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring: Our experience at Chandigarh, India
- Vision loss due to atypical bilateral edema of the optic nerve in a patient with hereditary angioedema: A case report
- WHAT LESSONS ARE LEARNED? OUR CHANGING PRACTICE DURING THIRTY YEARS OF HEREDITARY ANGIOEDEMA TREATMENT
- What lessons are learned?: Our changing practice during 30 years of hereditary angioedema treatment